Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial-Reference-Cited by-同舟云学术

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial

Published:2023-01 Issue:1 Volume:24 Page:64-76
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Mina Roberto^ORCID,Musto Pellegrino^ORCID,Rota-Scalabrini Delia^ORCID,Paris Laura^ORCID,Gamberi Barbara^ORCID,Palmas Angelo^ORCID,Aquino Sara^ORCID,de Fabritiis Paolo^ORCID,Giuliani Nicola^ORCID,De Rosa Luca^ORCID,Gozzetti Alessandro^ORCID,Cellini Claudia^ORCID,Bertamini Luca^ORCID,Capra Andrea^ORCID,Oddolo Daniela^ORCID,Vincelli Iolanda Donatella^ORCID,Ronconi Sonia^ORCID,Pavone Vincenzo^ORCID,Pescosta Norbert^ORCID,Cea Michele^ORCID,Fioritoni Francesca^ORCID,Ballanti Stelvio^ORCID,Grasso Mariella^ORCID,Zamagni Elena^ORCID,Belotti Angelo^ORCID,Boccadoro Mario^ORCID,Gay Francesca^ORCID

Publisher

Elsevier BV

Subject

Oncology

Reference36 articles.

1. Development and validation of a cytogenetic prognostic index predicting survival in multiple myeloma;Perrot;J Clin Oncol,2019

2. Interpretation of cytogenetic results in multiple myeloma for clinical practice;Rajan;Blood Cancer J,2015

3. Revised international staging system for multiple myeloma: a report from international myeloma working group;Palumbo;J Clin Oncol,2015

4. Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response;Abdallah;Blood Cancer J,2020

5. Long-term follow-up results of lenalidomide, bortezomib, and dexamethasone induction therapy and risk-adapted maintenance approach in newly diagnosed multiple myeloma;Joseph;J Clin Oncol,2020

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Maintenance Therapy in the Treatment of Newly Diagnosed Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival;Journal of Clinical Oncology;2024-08-10

3. Diagnosis and initial treatment of transplant‐eligible high‐risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper;British Journal of Haematology;2024-07

4. Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-06-28

5. Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies;American Society of Clinical Oncology Educational Book;2024-06